3-(5-)-Amino-o-diarylisoxazoles: regioselective synthesis and antitubulin activity. 2014

Dmitry V Tsyganov, and Victor N Khrustalev, and Leonid D Konyushkin, and Mikhail M Raihstat, and Sergei I Firgang, and Roman V Semenov, and Alex S Kiselyov, and Marina N Semenova, and Victor V Semenov
N. D. Zelinsky Institute of Organic Chemistry RAS, 47 Leninsky Prospect, 119991 Moscow, Russian Federation. Electronic address: tsyg@ioc.ac.ru.

A regioselective synthesis of both 5-amino- and 3-aminodiarylisoxazoles substituted with polyalkoxyaryl pharmacophores has been validated. Starting materials for the synthetic scheme were easily available from plant extracts. The targeted molecules were further tested in the phenotypic sea urchin embryo assay to identify compounds with antimitotic microtubule destabilizing activity. Structure-activity relationship studies suggested that the structural features essential for potent antiproliferative activity include: 1) 5-aminoisoxazole bridge linking biaryl substituents (rings A and B); 2) unsubstituted 5-amino group; 3) 3,4,5-methoxy substituted benzene and 4-methoxy benzene pharmacophores as rings A and B, respectively. The most potent compounds also showed strong in vitro cytotoxicity in NCI60 anticancer drug screen against a panel of 60 human cancer cell lines, including multi-drug resistant cells.

UI MeSH Term Description Entries
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012617 Sea Urchins Somewhat flattened, globular echinoderms, having thin, brittle shells of calcareous plates. They are useful models for studying FERTILIZATION and EMBRYO DEVELOPMENT. Echinoidea,Sand-Dollar,Clypeasteroida,Sand Dollars,Clypeasteroidas,Dollar, Sand,Dollars, Sand,Echinoideas,Sand Dollar,Sand-Dollars,Sea Urchin,Urchin, Sea,Urchins, Sea
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Dmitry V Tsyganov, and Victor N Khrustalev, and Leonid D Konyushkin, and Mikhail M Raihstat, and Sergei I Firgang, and Roman V Semenov, and Alex S Kiselyov, and Marina N Semenova, and Victor V Semenov
January 1985, Nucleic acids symposium series,
Dmitry V Tsyganov, and Victor N Khrustalev, and Leonid D Konyushkin, and Mikhail M Raihstat, and Sergei I Firgang, and Roman V Semenov, and Alex S Kiselyov, and Marina N Semenova, and Victor V Semenov
June 2004, Biotechnology letters,
Dmitry V Tsyganov, and Victor N Khrustalev, and Leonid D Konyushkin, and Mikhail M Raihstat, and Sergei I Firgang, and Roman V Semenov, and Alex S Kiselyov, and Marina N Semenova, and Victor V Semenov
June 2006, Journal of medicinal chemistry,
Dmitry V Tsyganov, and Victor N Khrustalev, and Leonid D Konyushkin, and Mikhail M Raihstat, and Sergei I Firgang, and Roman V Semenov, and Alex S Kiselyov, and Marina N Semenova, and Victor V Semenov
November 2007, Medicinal chemistry (Shariqah (United Arab Emirates)),
Dmitry V Tsyganov, and Victor N Khrustalev, and Leonid D Konyushkin, and Mikhail M Raihstat, and Sergei I Firgang, and Roman V Semenov, and Alex S Kiselyov, and Marina N Semenova, and Victor V Semenov
August 1987, Nucleic acids research,
Dmitry V Tsyganov, and Victor N Khrustalev, and Leonid D Konyushkin, and Mikhail M Raihstat, and Sergei I Firgang, and Roman V Semenov, and Alex S Kiselyov, and Marina N Semenova, and Victor V Semenov
November 1981, The Journal of antibiotics,
Dmitry V Tsyganov, and Victor N Khrustalev, and Leonid D Konyushkin, and Mikhail M Raihstat, and Sergei I Firgang, and Roman V Semenov, and Alex S Kiselyov, and Marina N Semenova, and Victor V Semenov
June 2010, The Journal of organic chemistry,
Dmitry V Tsyganov, and Victor N Khrustalev, and Leonid D Konyushkin, and Mikhail M Raihstat, and Sergei I Firgang, and Roman V Semenov, and Alex S Kiselyov, and Marina N Semenova, and Victor V Semenov
September 1990, Journal of medicinal chemistry,
Dmitry V Tsyganov, and Victor N Khrustalev, and Leonid D Konyushkin, and Mikhail M Raihstat, and Sergei I Firgang, and Roman V Semenov, and Alex S Kiselyov, and Marina N Semenova, and Victor V Semenov
June 2010, Macromolecular bioscience,
Dmitry V Tsyganov, and Victor N Khrustalev, and Leonid D Konyushkin, and Mikhail M Raihstat, and Sergei I Firgang, and Roman V Semenov, and Alex S Kiselyov, and Marina N Semenova, and Victor V Semenov
June 2003, Organic letters,
Copied contents to your clipboard!